20 Results for "

relaxin

" in MedChemExpress (MCE) Product Catalog:
Products (20)

20 Results for "relaxin" in MCE Product Catalog:

1
1 Cited Publications
Referencia número: HY-148087
No. CAS: 2787501-83-9
Pureza:  99.89%
Target:  

RXFP Receptor

Áreas de investigación:  

Cardiovascular Disease

AZD5462 is a RXFP1 modulator, can be used for heart failure research. RXFP1 is the cognate receptor for human relaxin, belongs to GPCR family 1c number with anti-fibrotic and anti-inflammatory properties .
loading...
    loading...
Referencia número: HY-112606
No. CAS: 1482500-76-4
Pureza:  99.81%
Target:  

RXFP Receptor

Áreas de investigación:  

Others

ML-290 is a first-in-class and potent relaxin/insulin-like family peptide receptor (RXFP1) agonist and activator of anti-fibrotic genes, with an EC50 of 94 nM . ML290 is a biased allosteric agonist at the relaxin receptor RXFP1.
loading...
    loading...
Referencia número: HY-P10728
No. CAS: 1818415-56-3
Target:  

RXFP Receptor ERK

Áreas de investigación:  

Cardiovascular Disease Inflammation/Immunology

B7-33 is a single-chain relaxin mimetic and a selective relaxin receptor 1 (RXFP1) agonist. B7-33 phosphorylates ERK1/2 without inducing activation of the cAMP signaling pathway. B7-33 exhibits anti-fibrotic and cardioprotective activities. B7-33 can be used in the research of vascular diseases such as cardiomyopathy, myocardial infarction and fibrosis .
loading...
    loading...
Referencia número: HY-150700
No. CAS: 2784577-71-3
Pureza:  99.79%
Target:  

ERK

Áreas de investigación:  

Metabolic Disease

RLX-33 is a potent, selective and blood-brain barrier (BBB) penetrant relaxin family peptide 3 (RXFP3) antagonist, also blocks relaxin-3-induced ERK1/2 phosphorylation, with IC50 values of 2.36 μM for RXFP3, 7.82 and 13.86 μM for ERK1 and ERK2 phosphorylation, respectively. RLX-33 can block the stimulation of food intake induced by the RXFP3-selective agonist R3/I5 in rats. RLX-33 can be used for the research of metabolic syndrome .
loading...
    loading...
Referencia número: HY-162401
No. CAS: 2813866-27-0
Target:  

RXFP Receptor

Áreas de investigación:  

Cardiovascular Disease

AZ7976 (Compound 42) is a highly selective agonist for the Relaxin Family Peptide Receptor 1 (RXFP1) (pEC50 > 10.5). AZ7976 enhances RXFP1's cAMP signaling through an allosteric mechanism, thereby physiologically increasing heart rate. AZ7976 can be used in the field of cardiovascular disease research .
loading...
    loading...
Referencia número: HY-P4890
No. CAS: 1158181-62-4
Relaxin H3 (human) is a relaxin peptide with anti-inflammatory, anti-apoptotic, anti-pyroptotic, anti-migratory, protective and anti-fibrotic activities. Relaxin H3 (human) acts on RXFP1 to generate cAMP and reduce the levels of ATP and ROS. Relaxin H3 (human) inhibits renal inflammatory pyroptosis (pyroptosis), NLRP3 inflammasome activation, caspase-1 activation, IL-1β/IL-18 secretion, collagen synthesis, TGF-β1 signaling pathway, Smad2 phosphorylation, myofibroblast differentiation, TIMP expression, and HRMEC migration. Relaxin H3 (human) activates AMPK, upregulates MFN2 expression, improves mitochondrial quality control and membrane potential, inhibits apoptosis (apoptosis) and pyroptosis, restores retinal ultrastructure, and reverses excessive left ventricular collagen expression. Relaxin H3 (human) can be used in studies related to kidney stones, nephrocalcinosis, diabetic cardiomyopathy, fibrotic cardiomyopathy, and diabetic retinopathy .
loading...
    loading...
Referencia número: HY-P4890A
Relaxin H3 (human) TFA is a relaxin peptide with anti-inflammatory, anti-apoptotic, anti-pyroptotic, anti-migratory, protective and anti-fibrotic activities. Relaxin H3 (human) TFA acts on RXFP1 to generate cAMP and reduce the levels of ATP and ROS. Relaxin H3 (human) TFA inhibits renal inflammatory pyroptosis (pyroptosis), NLRP3 inflammasome activation, caspase-1 activation, IL-1β/IL-18 secretion, collagen synthesis, TGF-β1 signaling pathway, Smad2 phosphorylation, myofibroblast differentiation, TIMP expression, and HRMEC migration. Relaxin H3 (human) TFA activates AMPK, upregulates MFN2 expression, improves mitochondrial quality control and membrane potential, inhibits apoptosis (apoptosis) and pyroptosis, restores retinal ultrastructure, and reverses excessive left ventricular collagen expression. Relaxin H3 (human) TFA can be used in studies related to kidney stones, nephrocalcinosis, diabetic cardiomyopathy, fibrotic cardiomyopathy, and diabetic retinopathy .
loading...
    loading...
Referencia número: HY-111583
No. CAS: 2351104-40-8
Target:  

RXFP Receptor

Áreas de investigación:  

Metabolic Disease

RXFP3/4 agonist 1 is an agonist of relaxin family peptide 3/4 receptor (RXFP3/4), with EC50s of 82/2 nM, respectivley. RXFP3/4 agonist 1 increases food intake in rats .
loading...
    loading...
Referencia número: HY-P991133
No. CAS: 2969217-22-7

Target:  

RXFP Receptor

Áreas de investigación:  

Cardiovascular Disease

Efranarelaxin alfa is a relaxin receptor agonist. Efranarelaxin alfa is promising for research of cardiovascular diseases and tissue repair .
loading...
    loading...
Referencia número: HY-174334
No. CAS: 2924765-23-9
Target:  

RXFP Receptor

Áreas de investigación:  

Cardiovascular Disease

RXFP1 receptor agonist-9 is a potent RXFP1 agonist with an EC50 of 2.5 μM and Ymax of 65%. RXFP1 receptor agonist-9 exhibits good microsomal stability, reasonable PK and pharmacological activity. RXFP1 receptor agonist-9 can be used to the study of heart failure .
loading...
    loading...
Referencia número: HY-P11619
Target:  

RXFP Receptor

Áreas de investigación:  

Cardiovascular Disease

R2R01 is a potent and selective relaxin family peptide receptor 1 (RXFP1) agonist with an EC50 of 0.34 nM. R2R01 activates RXFP1 to induce relaxin-like biological responses. R2R01 can increase heart rate in pithed and conscious rats. R2R01 can be used for the research of cardiovascular diseases .
loading...
    loading...
Referencia número: HY-P82110
Synonyms: Prorelaxin H2

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Referencia número: HY-P82110A
Synonyms: Prorelaxin H2

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Referencia número: HY-P77176
Pureza:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: RLN1; relaxin 1 (H1); relaxin 1; BA12D24.3.1; Prorelaxin H1; BA12D24.3.2; H1; H1RLX; Preprorelaxin H1; RLXH1
Species:  
Source:  
loading...
    loading...
Referencia número: HY-P11625
Target:  

RXFP Receptor

Áreas de investigación:  

Cardiovascular Disease

R9-13 is a fatty acid-conjugated relaxin and an agonist of LGR7 (RXFP1). R9-13 induces sustained pubic symphysis elongation in estrogen-pretreated mice. R9-13 exhibits long-acting pharmacokinetic profiles in rodents, with in vivo activity lasting up to one week after administration. R9-13 can be used in studies related to acute heart failure .
loading...
    loading...
Referencia número: HY-P81496
Synonyms: INSL3; RLF, RLNL; Insulin-like 3; Leydig insulin-like peptide (Ley-I-L); relaxin-like factor

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Referencia número: HY-P81496A
Synonyms: INSL3; RLF, RLNL; Insulin-like 3; Leydig insulin-like peptide (Ley-I-L); relaxin-like factor

Host:  

Rabbit

Application:  

IHC-P

Reactivity:  

Human

loading...
    loading...
Referencia número: HY-P70176
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: INSL3; Prepro-INSL3; Prev. RLNL; MGC119819; RLF; Ley-I-L; Insulin-Like 3 (Leydig Cell); Insulin-Like 3 (Leydig Cell), Isoform CRA_a; Leydig Insulin-Like Peptide; Leydig Insulin -Like Hormone; relaxin-Like Factor; relaxin-Like Factor B; Insulin-Like 3; Ins
Species:  
Source:  
loading...
    loading...
Referencia número: HY-P992108
No. CAS: 3061442-66-5
Synonyms: RELAX10

Áreas de investigación:  

Cardiovascular Disease

Efadirelaxin alfa (RELAX10) is a highly selective agonist of relaxin/insulin-like family peptide receptor RXFP1. After subcutaneous administration in animal experiments, Efadirelaxin alfa exhibits a significantly prolonged terminal half-life (7 days in mice, 3.75 days in rats), and shows no activity against related receptors such as RXFP2 and RXFP3. Efadirelaxin alfa has significant anti-cardiac hypertrophy and anti-fibrotic effects. Efadirelaxin alfa effectively attenuates and reverses cardiac hypertrophy and collagen deposition by regulating the TGF-β1/Smad2 and AKT/eNOS signaling pathways. Efadirelaxin alfa improves cardiac systolic function without causing fluctuations in blood pressure or heart rate, demonstrating favorable safety. Efadirelaxin alfa is currently mainly used in studies related to heart failure .
loading...
    loading...
Referencia número: HY-P76455
Pureza:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: INSL6; Insulin-Like Peptide INSL6; Insulin Like 6; Insulin-Like Peptide 6; RIF1; Insulin-Like Peptide 5; relaxin/Insulin-Like Factor 1; Insulin-Like 6
Species:  
Source:  
loading...
    loading...
  • 1